These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 17563252)
21. The management of patients with early Parkinson's disease. Rascol O; Brefel-Courbon C; Payoux P; Ferreira J Adv Neurol; 2003; 91():203-11. PubMed ID: 12442679 [No Abstract] [Full Text] [Related]
22. Combination pharmacotherapy in unipolar depression. Ng F; Dodd S; Berk M Expert Rev Neurother; 2006 Jul; 6(7):1049-60. PubMed ID: 16831118 [TBL] [Abstract][Full Text] [Related]
23. Clozapine use pattern in persons with and without treatment for Parkinson's disease in real-world conditions: a naturalistic study in a community-based sample. Verdoux H; Pambrun E Acta Psychiatr Scand; 2014 Dec; 130(6):487-97. PubMed ID: 25302631 [TBL] [Abstract][Full Text] [Related]
24. Optimizing therapeutic effects in patients with comorbidities: drug-resistant tremor, autonomic dysfunction, psychiatric disorders, and cognitive impairment. Chitnis S Neurol Clin; 2008 Aug; 26(3 Suppl):S29-44, v-vi. PubMed ID: 18774441 [TBL] [Abstract][Full Text] [Related]
25. Behavioral changes as side effects of medication treatment for Parkinson's disease. Hui JS; Murdock GA; Chung JS; Lew MF Adv Neurol; 2005; 96():114-29. PubMed ID: 16383216 [No Abstract] [Full Text] [Related]
26. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice. Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165 [TBL] [Abstract][Full Text] [Related]
27. Drug interactions in the treatment of Parkinson's disease. Jost WH; Brück C J Neurol; 2002 Oct; 249 Suppl 3():III/24-9. PubMed ID: 12522568 [TBL] [Abstract][Full Text] [Related]
28. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease. Chen JJ; Swope DM; Dashtipour K Clin Ther; 2007 Sep; 29(9):1825-49. PubMed ID: 18035186 [TBL] [Abstract][Full Text] [Related]
29. When a Parkinson's disease patient starts to hallucinate. Poewe W Pract Neurol; 2008 Aug; 8(4):238-41. PubMed ID: 18644910 [TBL] [Abstract][Full Text] [Related]
30. An approach to the psychopharmacologic care of patients: antidepressants, antipsychotics, anxiolytics, mood stabilizers, and natural remedies. Huffman JC; Alpert JE Med Clin North Am; 2010 Nov; 94(6):1141-60, x. PubMed ID: 20951275 [TBL] [Abstract][Full Text] [Related]